These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25555280)

  • 1. Exercise as the master polypill of the 21st century for the prevention of cardiovascular disease.
    Sanchis-Gomar F; Fiuza-Luces C; Lucia A
    Int J Cardiol; 2015 Feb; 181():360-1. PubMed ID: 25555280
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise prescription and primary prevention of cardiovascular disease.
    Metkus TS; Baughman KL; Thompson PD
    Circulation; 2010 Jun; 121(23):2601-4. PubMed ID: 20547940
    [No Abstract]   [Full Text] [Related]  

  • 3. What type of exercise prevents cardiovascular disease in postmenopausal women?
    Rivet C
    CMAJ; 2003 Feb; 168(3):314. PubMed ID: 12566338
    [No Abstract]   [Full Text] [Related]  

  • 4. The physiological paradox: reframing the polypill as a vaccine for cardiovascular disease.
    Holmes MV; Bhala N
    J Epidemiol Community Health; 2013 Nov; 67(11):897-902. PubMed ID: 23729329
    [No Abstract]   [Full Text] [Related]  

  • 5. Future of polypill use for the prevention of cardiovascular disease and strokes.
    Chrysant SG; Chrysant GS
    Am J Cardiol; 2014 Aug; 114(4):641-5. PubMed ID: 24996555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypill strategy for primary prevention of cardiovascular disorders.
    Dabhadkar KC; Bellam N
    Drugs Today (Barc); 2013 May; 49(5):317-24. PubMed ID: 23724411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach.
    Wald DS; Wald NJ
    J Eval Clin Pract; 2012 Jun; 18(3):612-5. PubMed ID: 21276141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.
    Carey KM; Comee MR; Donovan JL; Kanaan AO
    Ann Pharmacother; 2012 May; 46(5):688-95. PubMed ID: 22570437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evening versus morning polypill utilization study: the TEMPUS rationale and design.
    Lafeber M; Grobbee DE; Bots ML; Thom S; Webster R; Rodgers A; Visseren FL; Spiering W
    Eur J Prev Cardiol; 2014 Apr; 21(4):425-33. PubMed ID: 23382539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart health in older adults. Import of heart disease and opportunities for maintaining cardiac health.
    Fried LP; McNamara RL; Burke GL; Siscovick DS
    West J Med; 1997 Oct; 167(4):240-6. PubMed ID: 9348754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular polypill in high-risk patients.
    Lafeber M; Spiering W; Singh K; Guggilla RK; Patil V; Webster R;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1234-42. PubMed ID: 22019908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polypill in the primary prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Fundam Clin Pharmacol; 2010 Feb; 24(1):29-35. PubMed ID: 20002198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basketball for Health: Should We Hop and Shoot for a Remedy?
    Rátgéber L; Betlehem J; Calleja-Gonzalez J; Ostojic SM
    Mayo Clin Proc; 2019 Feb; 94(2):364-365. PubMed ID: 30711134
    [No Abstract]   [Full Text] [Related]  

  • 14. Polypill is not a 'vaccine-like' solution for primary cardiovascular disease prevention in all parts of the world.
    Reiner Z
    J Epidemiol Community Health; 2013 Dec; 67(12):981-2. PubMed ID: 24052514
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe.
    Thom S; Field J; Poulter N; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Rodgers A
    Eur J Prev Cardiol; 2014 Feb; 21(2):252-61. PubMed ID: 23038750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Validity of the Historical Leisure-time Physical Activity Question of the Spanish National Health Survey in Older Adults.
    Martínez-Gómez D; Guallar-Castillón P; Higueras-Fresnillo S; Rodríguez-Artalejo F
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):669-670. PubMed ID: 27789171
    [No Abstract]   [Full Text] [Related]  

  • 17. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 18. A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?
    Rastegarpanah M; Malekzadeh F; Thomas GN; Mohagheghi A; Cheng KK; Marshall T
    Arch Iran Med; 2008 May; 11(3):306-13. PubMed ID: 18426322
    [No Abstract]   [Full Text] [Related]  

  • 19. Interventions for cardiovascular disease prevention.
    Gupta R; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):15-34. PubMed ID: 21257098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [For an active prevention of cardiovascular diseases].
    Fabrégas B
    Soins; 2003; (672):14-5. PubMed ID: 12655817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.